COPPS-2
2014
COlchicine for Prevention of the Post-Pericardiotomy Syndrome and Post-operative Atrial Fibrillation 2
In 360 patients scheduled for cardiac surgery, perioperative colchicine started before surgery and continued for 1 month reduced postpericardiotomy syndrome within 3 months compared with placebo, but did not prevent postoperative atrial fibrillation.
Result
- Absolute difference
- 10.0 points
- NNT
- 10
absolute difference10.095% CI 1.1-18.7
Absolute difference and NNT are derived from the event rates.
Also reported: NNT 10). No benefit for postoperative atrial fibrillation (33.9 % vs 41.7 %). Adverse events 20.0 % vs 11.7 %, driven by gastrointestinal intolerance.
- Subtopic
- Postpericardiotomy syndrome
- Design
- Double-blind, placebo-controlled RCT
- Relevance
- Important: one of several pillars.
- Cited in
- ESC 2025 Myo/Pericarditis
- Source
- Imazio M, Brucato A, Ferrazzi P, et al. JAMA. 2014;312(10):1016-1023.doi 10.1001/jama.2014.11026
Discussion & critique
The preoperative start caused substantial gastrointestinal dropout, so the intention-to-treat benefit is smaller than in the earlier COPPS trial. It is the largest randomised evidence for colchicine prophylaxis after cardiac surgery and explains why it is endorsed for postpericardiotomy syndrome but not for postoperative atrial fibrillation.